Fig. 2

Compound-Target-Pathway interactions. By evaluating the absorption-associated properties of compounds, the 37 potential active compounds with 72 targets were used to construct the CTI network (a). The Potential Active Compound-Target and Pathway association network (b). By evaluating the metabolism-associated properties of compounds, the top 5 active compounds with 23 targets were used to construct the CTI network (c). Isorhamnetin and Kaempferide with 17 targets were used to construct the CTI network (d)